A federal decision to back away from the former Conservative government’s plans to make one type of opioid tamper resistant is setting off a contentious battle between the government, a major player in the narcotic-painkiller market and chronic pain specialists, many with ties to that company.
Tamper resistance is when drug manufacturers make opioids harder to crush, dissolve or otherwise manipulate for (more…)
TORONTO, Aug 28, 2014 (GLOBE NEWSWIRE via COMTEX) —
Intellipharmaceutics International Inc. IPCI, +2.11% (I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced an enhancement of its Rexista™ abuse-deterrence technologies with a significant improvement designed to prevent overdose when more pills than prescribed are swallowed intact. Intellipharmaceutics’ (more…)